The chemotherapeutic formula revisited

Journal of Chemotherapy

Volumn 9, Issue SUPPL. 1, 1997, Pages 123-133

  Periti, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFACLOR; CEFEPIME; CEFODIZIME; CEFPIROME; CEPHALOSPORIN DERIVATIVE; ITRACONAZOLE; LINCOSAMIDE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; RIFABUTIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG MONITORING; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS; DRUG THERAPY; HUMANS; MICROBIAL SENSITIVITY TESTS; PREDICTIVE VALUE OF TESTS;

EID: 0030745390     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Williams D. Susceptibility testing. Antibiot Chemother 1997; 1: 15-16.
2. a Ed. UTET, Torino 1994: 85-97.
3. Goldstein F, Soussy C-J, Thabaut A. Definition of the clinical antibacterial spectrum of activity. Clin Microbiol Infect 1996; 2 (Suppl 1): S40-S45.
4. Chabbert YA. Sensibilité bacterienne aux antibiotiques. In: Bactériologie Médicale (Le Minor L, Véron M, Eds). Flammarion, Paris 1982: 204-212.
5. Courvalin P. Interpretive reading of in vitro antibiotic susceptibility tests (the antibiogramme). Clin Microbiol Infect 1996; 2 (Suppl 1): S26-S34.
6. Nix DE, Goodwin SD, Peloquin CA, Rotella DL, Schentag JJ. Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response. Antimicrob Agents Chemother 1991; 35: 1953-1959.
7. Mini E, Novelli A, Periti P. Concentration-effect relationship for antimicrobial drugs. Proceedings of the First International Conference on Progress in Pathogen-Antibiotic Interactions. Turin, Italy - September 21-23, 1989. J Chemother 1991; 3 (Suppl 1): 149-154.
8. Novelli A, Ciuffi M, Reali UM, Mazzei T, Periti P. The suction blister technique as a tool in antimicrobial drug pharmacokinetics. Drugs Exp Clin Res 1983; 9: 555-559.
9. Mazzei T, Periti P. Tissue distribution of antimicrobial drugs. J Chemother 1989; 1 (2): 75-79.
10. Zack O, O'Reilly T. Animal models as predictors of the safery and efficacy of antibiotics. Eur J Clin Microbiol Infect Dis 1990; 9 (7): 472-478.
11. Tramont EC. General or nonspecific host defense mechanisms. In: Principles and Practice of Infectious Diseases (Mandell GL, Douglas RG, Bennett JE, Eds), Third Ed. Churchill Livingstone, New York 1990: 33-41.
12. Nichols WW. Towards a fundamental understanding of the MIC of β-lactam antibiotics. J Antimicrob Chemother 1988; 22: 275-283.
13. Brown MRW, Collier PJ, Gilbert P. Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrob Agents Chemother 1990; 34 (9): 1623-1628.
14. Mouton Y, Senneville E. Broad- versus narrow-spectrum antibiotic use: the role of in vitro testing and its correlation with clinical efficacy. Postgrad Med J 1992; 68 (Suppl 3): S68-S72.
15. Thornsberry C. Cefaclor AF: correlation of microbiology and clinical outcome. Postgrad Med J 1992; 68 (Suppl 3): S10-S16.
16. Wiedemann B. European Study Group on Antibiotic Breakpoints. Breakpoint determination: cefepime. Eur J Clin Microbiol Infect Dis 1994; 13 (3): 282-283.
17. Shah PM, Schäfer V, Ziemen M, Krauskopf S, and Microbiological and Clinical Study Group. Comparison of clinical response to cefpirome treatment and minimum inhibitory concentration of causative isolates. J Antimicrob Chemother 1992; 29 (Suppl A): 75-80.
18. Bryan LE. Leading article. Two forms of antimicrobial resistance: bacterial persistence and positive function resistance. J Antimicrob Chemother 1989; 23: 817-823.
19. Greenwood D. Leading article. Phenotypic resistance to antimicrobial agents. J Antimicrob Chemother 1985; 15: 653-658.